SLS Annual Accounts Payable
$5.64 M
+$2.28 M+67.98%
31 December 2023
Summary:
As of January 23, 2025, SLS annual accounts payable is $5.64 million, with the most recent change of +$2.28 million (+67.98%) on December 31, 2023. During the last 3 years, it has risen by +$982.00 thousand (+21.09%). SLS annual accounts payable is now -51.77% below its all-time high of $11.69 million, reached on December 31, 2017.SLS Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SLS Quarterly Accounts Payable
$4.55 M
-$1.78 M-28.18%
30 September 2024
Summary:
As of January 23, 2025, SLS quarterly accounts payable is $4.55 million, with the most recent change of -$1.78 million (-28.18%) on September 30, 2024. Over the past year, it has dropped by -$1.09 million (-19.37%). SLS quarterly accounts payable is now -62.42% below its all-time high of $12.10 million, reached on June 30, 2018.SLS Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SLS Accounts Payable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +68.0% | -19.4% |
| 3 y3 years | +21.1% | +21.8% |
| 5 y5 years | +50.2% | +21.8% |
SLS Accounts Payable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +163.0% | -38.6% | +113.8% |
| 5 y | 5-year | at high | +163.0% | -38.6% | +155.6% |
| alltime | all time | -51.8% | -62.4% |
SELLAS Life Sciences Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $4.55 M(-28.2%) |
| June 2024 | - | $6.33 M(-14.5%) |
| Mar 2024 | - | $7.41 M(+31.4%) |
| Dec 2023 | $5.64 M(+68.0%) | $5.64 M(+29.9%) |
| Sept 2023 | - | $4.34 M(+16.2%) |
| June 2023 | - | $3.73 M(+20.5%) |
| Mar 2023 | - | $3.10 M(-7.7%) |
| Dec 2022 | $3.36 M(+56.6%) | $3.36 M(+57.8%) |
| Sept 2022 | - | $2.13 M(-36.3%) |
| June 2022 | - | $3.34 M(+17.5%) |
| Mar 2022 | - | $2.84 M(+32.6%) |
| Dec 2021 | $2.14 M(-54.0%) | $2.14 M(-15.8%) |
| Sept 2021 | - | $2.54 M(+11.8%) |
| June 2021 | - | $2.28 M(-3.1%) |
| Mar 2021 | - | $2.35 M(-49.5%) |
| Dec 2020 | $4.66 M(+19.3%) | $4.66 M(+161.8%) |
| Sept 2020 | - | $1.78 M(-26.7%) |
| June 2020 | - | $2.43 M(-7.5%) |
| Mar 2020 | - | $2.62 M(-32.8%) |
| Dec 2019 | $3.90 M(+3.9%) | $3.90 M(+3.7%) |
| Sept 2019 | - | $3.76 M(+0.1%) |
| June 2019 | - | $3.76 M(-18.9%) |
| Mar 2019 | - | $4.64 M(+23.5%) |
| Dec 2018 | $3.75 M(-67.9%) | $3.75 M(-48.1%) |
| Sept 2018 | - | $7.24 M(-40.2%) |
| June 2018 | - | $12.10 M(+5.7%) |
| Mar 2018 | - | $11.45 M(-2.1%) |
| Dec 2017 | $11.69 M(>+9900.0%) | $11.69 M(+5440.8%) |
| Sept 2017 | - | $211.00 K(-45.2%) |
| June 2017 | - | $385.00 K(-66.9%) |
| Mar 2017 | - | $1.16 M(>+9900.0%) |
| Dec 2016 | $0.00(-100.0%) | $0.00(-100.0%) |
| Sept 2016 | - | $894.00 K(-29.8%) |
| June 2016 | - | $1.27 M(+24.9%) |
| Mar 2016 | - | $1.02 M(-36.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2015 | $1.60 M(-15.3%) | $1.60 M(+29.0%) |
| Sept 2015 | - | $1.24 M(-46.6%) |
| June 2015 | - | $2.32 M(-29.6%) |
| Mar 2015 | - | $3.29 M(+74.6%) |
| Dec 2014 | $1.89 M(-29.1%) | $1.89 M(-43.9%) |
| Sept 2014 | - | $3.36 M(+65.0%) |
| June 2014 | - | $2.04 M(+29.4%) |
| Mar 2014 | - | $1.57 M(-40.8%) |
| Dec 2013 | $2.66 M(+34.6%) | $2.66 M(+40.7%) |
| Sept 2013 | - | $1.89 M(-9.7%) |
| June 2013 | - | $2.09 M(-1.5%) |
| Mar 2013 | - | $2.12 M(+7.4%) |
| Dec 2012 | $1.98 M(-8.3%) | $1.98 M(-10.6%) |
| Sept 2012 | - | $2.21 M(+29.5%) |
| June 2012 | - | $1.71 M(-33.9%) |
| Mar 2012 | - | $2.58 M(+19.8%) |
| Dec 2011 | $2.15 M(+197.7%) | $2.15 M(+47.4%) |
| Sept 2011 | - | $1.46 M(+37.3%) |
| June 2011 | - | $1.06 M(+46.7%) |
| Mar 2011 | - | $726.00 K(+0.3%) |
| Dec 2010 | $724.00 K(+15.8%) | $724.00 K(-13.4%) |
| Sept 2010 | - | $836.00 K(+154.1%) |
| June 2010 | - | $329.00 K(-70.7%) |
| Mar 2010 | - | $1.12 M(+79.4%) |
| Dec 2009 | $625.00 K(+58.6%) | $625.00 K(+17.0%) |
| Sept 2009 | - | $534.00 K(-7.9%) |
| June 2009 | - | $580.00 K(+41.8%) |
| Mar 2009 | - | $409.00 K(+3.8%) |
| Dec 2008 | $394.00 K(+616.4%) | $394.00 K(+49.2%) |
| Sept 2008 | - | $264.00 K(-43.9%) |
| June 2008 | - | $471.00 K(+96.3%) |
| Mar 2008 | - | $240.00 K(+336.4%) |
| Dec 2007 | $55.00 K(>+9900.0%) | $55.00 K(-38.2%) |
| Sept 2007 | - | $89.00 K(>+9900.0%) |
| Dec 2006 | $0.00 | $0.00 |
FAQ
- What is SELLAS Life Sciences annual accounts payable?
- What is the all time high annual accounts payable for SELLAS Life Sciences?
- What is SELLAS Life Sciences annual accounts payable year-on-year change?
- What is SELLAS Life Sciences quarterly accounts payable?
- What is the all time high quarterly accounts payable for SELLAS Life Sciences?
- What is SELLAS Life Sciences quarterly accounts payable year-on-year change?
What is SELLAS Life Sciences annual accounts payable?
The current annual accounts payable of SLS is $5.64 M
What is the all time high annual accounts payable for SELLAS Life Sciences?
SELLAS Life Sciences all-time high annual accounts payable is $11.69 M
What is SELLAS Life Sciences annual accounts payable year-on-year change?
Over the past year, SLS annual accounts payable has changed by +$2.28 M (+67.98%)
What is SELLAS Life Sciences quarterly accounts payable?
The current quarterly accounts payable of SLS is $4.55 M
What is the all time high quarterly accounts payable for SELLAS Life Sciences?
SELLAS Life Sciences all-time high quarterly accounts payable is $12.10 M
What is SELLAS Life Sciences quarterly accounts payable year-on-year change?
Over the past year, SLS quarterly accounts payable has changed by -$1.09 M (-19.37%)